| 发明名称 |
Use of Fulvestrant in the Treatment of Resistant Breast Cancer |
| 摘要 |
The invention relates to the use of fulvestrant in the treatment of breast cancer in patients who have previously been treated with a Selective Estrogen Receptor Modulator (SERM) and an aromatase inhibitor.
|
| 申请公布号 |
US2011183949(A1) |
申请公布日期 |
2011.07.28 |
| 申请号 |
US20100895369 |
申请日期 |
2010.09.30 |
| 申请人 |
THURLIMANN BEAT |
发明人 |
THURLIMANN BEAT |
| 分类号 |
A61K31/565;A61K31/138;A61K31/4196;A61K31/56;A61P35/00;A61P43/00;C07J1/00 |
主分类号 |
A61K31/565 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
